4//SEC Filing
Mackay Sean 4
Accession 0000950170-25-077191
CIK 0001162194other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:13 PM ET
Size
7.1 KB
Accession
0000950170-25-077191
Insider Transaction Report
Form 4
Mackay Sean
SVP & Chief Business Officer
Transactions
- Sale
Common Stock
2025-05-21$1.03/sh−12,838$13,223→ 868,829 total - Sale
Common Stock
2025-05-22$1.00/sh−12,536$12,561→ 856,293 total
Footnotes (3)
- [F1]The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission ("SEC") on March 24, 2025.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.
Documents
Issuer
STANDARD BIOTOOLS INC.
CIK 0001162194
Entity typeother
Related Parties
1- filerCIK 0001875501
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 6:13 PM ET
- Size
- 7.1 KB